The 21st International Molecular Medicine Tri-Conference is the industry’s Preeminent Event on Molecular Medicine, focusing on Drug Discovery, Genomics, Diagnostics and Information Technology.  Spanning six days this year, the Tri-Conference includes an expanded program that includes 6 symposia, over 20 short courses, and 15 main programs.  For the first time in over 10 years we’re bringing back a dedicated conference on sequencing. As many will recall this event’s infancy was heavily devoted to the Human Genome Project and we are excited to reintroduce sequencing to this event.   For over 20 years, Tri-Conference attendees gained insight and knowledge by attending, knowledge that they were able to take with them, and have an immediate impact on their research.  Plan to attend this year's Tri-Conference where you can be part of driving change and working towards shaping the future of medicine.

For speaker information, please visit our website.

Current exhibitors include:  

• Acumenta Biotech
• Advanced Cell Diagnostics
• Almac Group
• ALS Automated Lab Solutions GmbH
• Analytical Biological Services Inc. (ABS)
• Aragen Bioscience, Inc.
• Aspera
• Asuragen, Inc.
• Axxin
• Biocartis
• BioFortis
• Bioneer
• Bio-Options, Inc.
• Biosearch Technologies, Inc.
• BioView USA, Inc.
• Boreal Genomics
• Catholic Health Initiatives Institute for Research and Innovation
• Champions Oncology Inc.
• ChemAxon Kft.
• Collaborative Drug Discovery, (CDD) Inc.
• Cureline, Inc.
• Cycle Computing
• Definiens , Inc.
• Docro, Inc.
• Dotmatics
• Elsevier
• EKF Diagnostics
• Evotec
• Flagship Biosciences
• Fluxion Biosciences
• Folio Biosciences

For a full list of exhibitors, please visit our website.